Medicare Enrolled

Dr. Justin Matrisciano, MD

Endocrinology · Dartmouth, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
535 FAUNCE CORNER RD, Dartmouth, MA 02747
5089963991
In practice since 2005 (20 years)
NPI: 1922093210 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Matrisciano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Matrisciano? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Matrisciano

Dr. Justin Matrisciano is an endocrinology specialist in Dartmouth, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Matrisciano performed 5,345 Medicare services across 2,771 unique beneficiaries.

Between the years covered by Open Payments, Dr. Matrisciano received a total of $56,050 from 28 pharmaceutical and/or device companies across 230 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Matrisciano is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 8% volume in MA $56,050 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,345
Medicare services
Top 8% in MA for endocrinology
2,771
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~267 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,020 $18 $43
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
887 $97 $334
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
660 $8 $20
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
403 $10 $40
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
312 $9 $30
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
301 $16 $50
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
281 $122 $509
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
242 $10 $29
Creatinine test (kidney function)
A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury.
150 $5 $20
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
127 $3 $20
Magnesium level test
A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess.
124 $7 $20
Urine microalbumin test (kidney screening)
A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage.
71 $6 $40
Diabetes self-management training, individual
Individualized education and training for managing diabetes, billed per 30-minute session.
68 $40 $203
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
66 $13 $40
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
62 $133 $448
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
59 $7 $25
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
54 $11 $69
Parathyroid hormone level test
A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones.
53 $40 $120
Liver function blood test panel 36 $8 $40
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
32 $15 $49
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
31 $8 $40
Phosphate level test
A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong.
29 $5 $20
Folic acid level test
A blood test that measures the amount of folic acid in the serum.
27 $14 $45
Iron level test 27 $6 $20
Kidney function blood test panel 25 $9 $40
Iron binding capacity test
A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron.
25 $9 $26
Albumin level test
A blood test that measures the amount of albumin, a protein made by the liver, in your body.
21 $5 $40
Direct bilirubin level test
A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver.
21 $5 $20
Follicle stimulating hormone (FSH) level
A blood test to measure the level of follicle stimulating hormone, a reproductive hormone.
20 $18 $60
Luteinizing hormone level test
A blood test that measures the level of luteinizing hormone, a reproductive hormone. This test helps evaluate hormonal balance and reproductive function.
19 $18 $56
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
17 $13 $40
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
16 $2 $30
Blood glucose tolerance test, 3 specimens
A test that measures blood sugar levels at three different times to check how the body processes glucose.
16 $13 $40
Complete blood count (CBC), automated
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood.
16 $6 $20
New patient office visit, complex (60-74 min) 14 $160 $637
Injection, cosyntropin, 0.25 mg 13 $20 $294
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2022 ↗
$56,050
Total received (2018-2022)
Avg $11,210/year across 5 years
Top 9% in MA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
230
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$54,281 (96.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,769 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$2,182
2021
$13,469
2020
$5,346
2019
$13,523
2018
$21,529

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,050
Lilly USA, LLC
$997
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$57
Amgen Inc.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Medtronic, Inc.
$19
Top 3 companies account for 96.4% of 2022 payments
All-time payments by company (2018-2022) ›
SANOFI-AVENTIS U.S. LLC
$23,890
AbbVie, Inc.
$11,536
AbbVie Inc.
$8,403
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$4,651
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,731
Lilly USA, LLC
$2,469
ABBVIE INC.
$1,050
Novo Nordisk Inc
$266
Amgen Inc.
$195
Abbott Laboratories
$180
AstraZeneca Pharmaceuticals LP
$97
Janssen Pharmaceuticals, Inc
$80
Insulet Corporation
$62
Medtronic MiniMed, Inc.
$60
Becton, Dickinson and Company
$49
Gemini Laboratories, LLC
$39
Merck Sharp & Dohme Corporation
$38
Shire North American Group Inc
$35
Corcept Therapeutics
$33
IBSA Pharma Inc.
$31
Dexcom, Inc.
$30
Antares Pharma, Inc.
$28
Medtronic, Inc.
$19
Amarin Pharma Inc.
$17
Valeritas, Inc.
$16
Currax Pharmaceuticals LLC
$16
VIVUS, Inc.
$15
Amneal Pharmaceuticals LLC
$14
Top 3 companies account for 78.2% of all-time payments
Associated products mentioned in payments ›
APRISO · Aimovig · BAQSIMI · BD NANO · BYDUREON · CONTRAVE · CYCLOSET · Corlanor · DEXCOM CGM · DIABETES - DISEASE · Dexcom CGM · EVENITY · FARXIGA · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · FreeStyle Lite system · HUMULIN · HUMULIN R 500 · INVOKANA · JARDIANCE · Korlym · MINIMED 770G · MOUNJARO · Minimed 670G System · NATPARA · Omnipod · Otrexup · Ozempic · Prolia · QSYMIA · Repatha · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYNJARDY · SYNTHROID · Saxenda · Synthroid · TOUJEO · TRADJENTA · TRULICITY · Tirosint · UNITHROID · V-GO · Vascepa · Victoza · XARELTO · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for endocrinology in MA.

Looking for an endocrinology specialist in Dartmouth?
Compare endocrinologists in the Dartmouth area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
41
Per 100K population
7.1
County median income
$84,198
Nearest hospital
SOUTHCOAST BEHAVIORAL HEALTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2022
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Matrisciano is a clinical cardiology specialist, with above-average Medicare volume (top 8% in MA), with speaking/promotional industry engagement in the top 9% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Matrisciano experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Matrisciano performed 1,020 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Matrisciano receive payments from pharmaceutical companies?
Yes. Dr. Matrisciano received a total of $56,050 from 28 companies across 230 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Matrisciano's costs compare to other endocrinologists in Dartmouth?
Dr. Matrisciano's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Matrisciano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →